Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Koji Haratani, M.D., Ph.D.

Concepts (182)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Non-Small-Cell Lung26202452301.870 Why?
Lung Neoplasms282024131121.390 Why?
Receptor, erbB-3620211421.330 Why?
Neoplasms, Unknown Primary120191040.650 Why?
Lymphocytes, Tumor-Infiltrating3202010380.590 Why?
Biomarkers, Pharmacological120181620.590 Why?
Immunoconjugates220209010.520 Why?
Immune System Diseases120182610.520 Why?
Drug Resistance, Neoplasm10202351700.500 Why?
Neoplasms, Experimental1202012720.480 Why?
Acrylamides120152550.470 Why?
Protein Kinase Inhibitors11202255320.460 Why?
Tumor Microenvironment4202335830.450 Why?
Pyrimidines2202129450.310 Why?
Gene Expression Regulation, Neoplastic3202084300.310 Why?
Camptothecin220215760.290 Why?
Antibodies, Monoclonal4201792720.280 Why?
Mutation152023297770.280 Why?
Carcinoma, Squamous Cell4202140330.260 Why?
Receptor, erbB-24202124180.260 Why?
Proto-Oncogene Proteins p21(ras)2202216910.240 Why?
Antineoplastic Combined Chemotherapy Protocols72022115240.240 Why?
Xenograft Model Antitumor Assays6202035470.220 Why?
Paget Disease, Extramammary12021450.200 Why?
Genital Neoplasms, Male12021740.200 Why?
Antineoplastic Agents62020136910.190 Why?
Selective Estrogen Receptor Modulators120211290.190 Why?
Proto-Oncogene Proteins c-met220225790.190 Why?
Gene Amplification2202210630.180 Why?
Proto-Oncogene Proteins3202345520.180 Why?
Neuregulin-1220191420.180 Why?
Monitoring, Immunologic12019990.170 Why?
Pneumonia2202121330.170 Why?
Cell Line, Tumor92022166740.170 Why?
Adenocarcinoma2201763630.170 Why?
Hepatitis120202270.160 Why?
Kaplan-Meier Estimate2201965390.150 Why?
Melanoma, Experimental120205600.150 Why?
Carbazoles120192260.150 Why?
Neoplasms32023216750.150 Why?
Borrelia Infections12016170.140 Why?
Tamoxifen120219810.140 Why?
Maytansine12016800.140 Why?
Borrelia12016670.140 Why?
Cholangitis120171080.140 Why?
Patient Selection2201942100.140 Why?
Lyme Neuroborreliosis12016510.140 Why?
Extracellular Signal-Regulated MAP Kinases120186230.140 Why?
Humans4320247438110.130 Why?
Protein-Tyrosine Kinases2202324530.130 Why?
Aged, 80 and over92021577440.130 Why?
Aged1820211631780.120 Why?
Carboplatin320228010.120 Why?
Meningitis, Bacterial120162180.120 Why?
Immunomodulation120185410.120 Why?
Middle Aged1820212132410.110 Why?
Retrospective Studies102023774100.110 Why?
Prognosis82021290520.110 Why?
Japan3202113600.110 Why?
Esophageal Neoplasms1202215850.110 Why?
Histocompatibility Antigens Class I1201813660.100 Why?
Indoles1202018410.100 Why?
Treatment Outcome82021630420.100 Why?
Intercellular Signaling Peptides and Proteins1201916780.100 Why?
Disease Progression22019132730.100 Why?
Female2120213800200.100 Why?
Receptor Protein-Tyrosine Kinases1201916600.100 Why?
Proto-Oncogene Proteins B-raf1202120390.100 Why?
Cisplatin3202216620.100 Why?
Piperazines1202124870.090 Why?
Fatal Outcome1201518510.090 Why?
T-Lymphocytes, Cytotoxic1201818210.090 Why?
Piperidines1201916010.090 Why?
Quinazolines1201613560.090 Why?
Disease-Free Survival2201768950.090 Why?
Signal Transduction42021233980.090 Why?
Lymphocytes1201726150.090 Why?
Renal Dialysis1201917830.090 Why?
Pyridines1202128270.090 Why?
Leukocytes1201720440.090 Why?
Chemotherapy, Adjuvant1201834800.090 Why?
Male1920213497760.080 Why?
Immunohistochemistry22019113600.080 Why?
Neoplasm Staging12023110360.080 Why?
1-Alkyl-2-acetylglycerophosphocholine Esterase120081270.080 Why?
Dyneins120081230.080 Why?
Mice82022811540.070 Why?
Adult1020212138890.070 Why?
Stomach Neoplasms1201613320.070 Why?
Fluorouracil2202216190.070 Why?
Head and Neck Neoplasms1202127360.070 Why?
Follow-Up Studies42021390010.070 Why?
Cell Transformation, Neoplastic1201529420.070 Why?
Survival Rate42021127860.060 Why?
Neutrophils1201737180.060 Why?
Cytoplasm1200815360.060 Why?
Paclitaxel2202117050.060 Why?
Ligands2202232810.060 Why?
Gene Expression Profiling1201994400.060 Why?
Microtubule-Associated Proteins1200810830.060 Why?
Tumor Cells, Cultured2202163110.060 Why?
Animals920221686600.050 Why?
Neoplasm Recurrence, Local1202192390.050 Why?
Lung1202198580.050 Why?
Immunotherapy1201844370.050 Why?
5'-Nucleotidase120221600.050 Why?
Oxycodone120231530.050 Why?
Catechol O-Methyltransferase120232450.050 Why?
Breast Neoplasms22019208270.050 Why?
Genes, ras120226900.040 Why?
Phenotype12017163610.040 Why?
Time Factors22021400380.040 Why?
Colorectal Neoplasms1201967730.040 Why?
Taxoids120226660.040 Why?
Plasma Exchange120201520.040 Why?
HT29 Cells120192000.040 Why?
Bronchoalveolar Lavage Fluid120217680.040 Why?
Albumins120215680.040 Why?
Cell Proliferation32020104770.040 Why?
High-Throughput Nucleotide Sequencing2202135910.040 Why?
Morphine120236570.040 Why?
Topoisomerase I Inhibitors12018650.040 Why?
DNA Topoisomerases, Type I120181020.040 Why?
Apoptosis3202097180.040 Why?
HCT116 Cells120194090.040 Why?
Oncogene Protein v-akt120161350.040 Why?
Tumor Burden1202119170.030 Why?
Inhibitor of Apoptosis Proteins120162150.030 Why?
Drug Compounding120172410.030 Why?
Genetic Predisposition to Disease12017174390.030 Why?
Ceftriaxone120161680.030 Why?
Bronchoscopy120218610.030 Why?
Cohort Studies12018405450.030 Why?
Carrier Proteins1200850210.030 Why?
Doxycycline120163260.030 Why?
Immunologic Factors1202415800.030 Why?
Injections, Intravenous1201714220.030 Why?
Safety1201911840.030 Why?
Lymphatic Metastasis1202129240.030 Why?
Drug Administration Schedule1202149310.030 Why?
Proto-Oncogene Proteins c-akt1202125040.030 Why?
Mice, Nude1201936800.030 Why?
Facial Paralysis120163380.030 Why?
Phosphatidylinositol 3-Kinases1202129380.030 Why?
Neoadjuvant Therapy1202227270.030 Why?
MAP Kinase Signaling System1201815240.020 Why?
Down-Regulation1201830000.020 Why?
Antibodies, Bacterial1201614700.020 Why?
Sequence Analysis, DNA1202148030.020 Why?
Mice, Inbred BALB C1201963800.020 Why?
Disease Models, Animal22019180270.020 Why?
Biopsy1202167500.020 Why?
Fluorescence Recovery After Photobleaching12008560.020 Why?
Survival Analysis12021102510.020 Why?
Genetic Testing1202134390.020 Why?
Cell Survival1201958810.020 Why?
Genotype12023129440.020 Why?
Multivariate Analysis12021122430.020 Why?
Pain1202349870.020 Why?
Genomics1202357140.020 Why?
Phosphorylation1201884360.020 Why?
Antibodies, Neutralizing1201719780.020 Why?
Analgesics, Opioid1202336770.020 Why?
Molecular Targeted Therapy1201827270.020 Why?
Gene Expression1201977930.020 Why?
Drug Therapy, Combination1201664870.020 Why?
CD8-Positive T-Lymphocytes1201844770.020 Why?
Tubulin120086950.020 Why?
Biological Transport1200821190.010 Why?
Incidence12021209480.010 Why?
Mice, Inbred C57BL12020218240.010 Why?
Microtubules1200810870.010 Why?
Severity of Illness Index12020155260.010 Why?
Liver1201774790.010 Why?
Recombinant Fusion Proteins1200837720.010 Why?
Risk Assessment12021233270.010 Why?
Swine1200859090.010 Why?
Anti-Bacterial Agents1201671720.010 Why?
Prospective Studies12021532500.010 Why?
Risk Factors12021722520.010 Why?
Cell Line12008159930.010 Why?
Neurons1200893360.010 Why?
Haratani's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (182)
Explore
_
Co-Authors (12)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.